Clinical Trial: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038343) titled 'Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)' on June 18.

Brief Summary: This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-1418 when administered intravenously as a monotherapy and potentially in combination therapy to patients with locally advanced or metastatic epithelial solid tumors.

Study Start Date: June 19

Study Type: INTERVENTIONAL

Condition: Solid Tumor Cancer Locally Advanced Metastatic Sol...